doi: 10.1016/0262-1746(85)90005-8.
Inhibition by aspirin of human arterial and venous prostacyclin synthesis
- PMID: 3906670
- DOI: 10.1016/0262-1746(85)90005-8
Item in Clipboard
Inhibition by aspirin of human arterial and venous prostacyclin synthesis
Prostaglandins Leukot Med.
1985 Nov.
Abstract
Prostacyclin (PGI2) synthesis by human mesenteric arteries and veins was measured ex vivo in 62 patients who received either no medication or a single oral dose of aspirin 40 mg, 75 mg or 300 mg approximately 24 hrs pre-operatively. Each dose of aspirin caused a significant reduction in both arterial and venous PGI2 synthesis compared with the untreated group. Arterial PGI2 synthesis did not differ significantly from venous PGI2 synthesis whether assessed by sample weight or sample area.
Similar articles
-
Failure of salicylate to reduce inhibition of human venous prostacyclin in synthesis by conventional dose aspirin.Thromb Haemost. 1983 Feb 28;49(1):51-2. Thromb Haemost. 1983. PMID: 6342201
-
Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients.N Engl J Med. 1983 Apr 7;308(14):800-5. doi: 10.1056/NEJM198304073081402. N Engl J Med. 1983. PMID: 6339916
-
Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):387-97. doi: 10.1097/00005344-198007000-00006. J Cardiovasc Pharmacol. 1980. PMID: 6156337
-
Prostacyclin.Prog Hemost Thromb. 1982;6:113-38. Prog Hemost Thromb. 1982. PMID: 6762610 Review. No abstract available.
-
Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.Circulation. 1980 Dec;62(6 Pt 2):V19-25. Circulation. 1980. PMID: 7002350 Review.
Cited by
-
Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy.Br J Clin Pharmacol. 2011 Oct;72(4):619-33. doi: 10.1111/j.1365-2125.2011.03943.x. Br J Clin Pharmacol. 2011. PMID: 21320154 Free PMC article. Review.
-
Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels.J Clin Invest. 1986 Jul;78(1):323-6. doi: 10.1172/JCI112569. J Clin Invest. 1986. PMID: 3088044 Free PMC article.
-
The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2-mediated relaxation.Br J Pharmacol. 1999 Jan;126(1):35-44. doi: 10.1038/sj.bjp.0702265. Br J Pharmacol. 1999. PMID: 10051118 Free PMC article.